OBLN News and Press, Obalon Therapeutics From 03/12/21

Obalon Therapeutics (OBLN): Q4 GAAP EPS of -$0.17 misses by $0.11.Revenue of $0.1M (-87.3% Y/Y)Press Release For further details see: Obalon Therapeutics EPS misses by $0.11

SAN DIEGO, March 12, 2021 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity, today announced its financial resu...

MediciNova (MNOV) +87% on BARDA partnership for Ibudilast development.Cemtrex (CETX) +85%.Koss Corporation (KOSS) +50%.Obalon Therapeutics (OBLN) +34%.Enveric Biosciences (ENVB) +39% on agreement to acquire exclusive license for novel molecules from Diverse Biotech.MoneyGram Interna...

Obalon Therapeutics (OBLN) has gained ~28.3% in pre-market trading. With a ~136.0% in the year so far, the medical device company focused on treating obesity has more than tripled in value in the past-12-month period.An article on Own Snap suggests investors ‘put th...

Penny Stocks to Watch As Markets Try To Recover With major blue-chip stocks pushing up by big numbers on Tuesday, which penny stocks are investors watching? Now this question comes with multiple parts as it truly depends on a few factors. Overall, we have to consider the current state o...

Helius Medical Technologies (HSDT) -17%.Avinger (AVGR) -12%.Cango (CANG) -11%.OncoCyte (OCX) -10%.Obalon Therapeutics (OBLN) -10%.Dolphin Entertainment (DLPN) -9%.Surgalign Holdings (SRGA) -8% after pricing equity offering at $1.50.Vertex Energy (VTNR) -7%.Atossa Therapeutics (ATOS)...

The market is starting to encounter some volatility after mostly smooth sailing since November. While, there's good reason to believe this dip is buyable, investors need to be wary that certain stocks are starting to underperform such as GMBL, ZSAN, OBLN, and USAP. The stock market is hit...

Repro Med Systems (KRMD) -18% on preliminary FY20 results and CEO transition.Sanchez Midstream Partners (SNMP) -17%.Express (EXPR) -16% as Wedbush sees company 'hemorrhaging cash'.Lipocine (LPCN) -14% on launch of public offering.Midatech Pharma (MTP) -10%&#...

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. The Dow Jones and S&P 500 indexes fell slightly on Friday but clawed back from their worst losses, while the Nasdaq edged higher to another record clos...

Gainers: Adamis Pharmaceuticals (ADMP) +47%, AzurRx BioPharma (AZRX) +38%, 111 (YI) +27%, Obalon Therapeutics (OBLN) +17%, iBio (IBIO) +17%.Losers: Celsion CLSN -18%, ViewRay VRAY -14%, ADiTx Therapeutics (ADTX) -14%, Passage Bio PASG ...